Zhongzhu Healthcare Holding Co (SHSE:600568) FFO


SHSE:600568 Zhongzhu Healthcare Holding Co Ltd SHSE:600568
55 GF Score
Price ¥2.41
GF Value ¥1.88
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Zhongzhu Healthcare Holding Co FFO?

FFO (Funds from operations) only applies to REITs.

SHSE:600568
55GF Score
Zhongzhu Healthcare Holding Co Ltd SHSE:600568
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Zhongzhu Healthcare Holding Co (SHSE:600568) Overvalued in 2026?

Based on GuruFocus' analysis, Zhongzhu Healthcare Holding Co stock appears to be overvalued. The current stock price of ¥2.41 is trading 28.2% above its estimated GF Value™ of ¥1.88. GuruFocus considers Zhongzhu Healthcare Holding Co to be Modestly Overvalued.

Key valuation signals for SHSE:600568:

  • FFO:
  • GF Value™: ¥1.88 vs. price of ¥2.41 (28.2% above fair value)
  • GF Score™: 55/100 with 3 warning signs

No single metric tells the full story. See the SHSE:600568 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zhongzhu Healthcare Holding Co Business Description

Address No. 1 Qinglu South Road, 8th Floor, Building 5, Yanlord Marina Center, Zhuhai, CHN, 519020
Zhongzhu Healthcare Holding Co Ltd produces and sells ophthalmic, antiviral, and anti-infective drugs in China. Its products include eye and nasal drops, injections, solid preparations, and other products. The product consists of Pearl Eye Drops, Sodium Cromolyn Eye Drops, Acyclovir Eye Drops, Hydroxybenzazole Hydrochloride Eye Drops, Acyclovir Dispersible Tablets, Gatifloxacin Tablets.
55GF Score

Get the complete analysis for SHSE:600568

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥2.41
Price
¥1.88
GF Value